What does CUSIP G9495L109 represent in this 13F holders report?

CUSIP G9495L109 is the security identifier for VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock used to aggregate holder disclosures.

How many institutions held VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock in Q4 2023?

No institutional holders were reported for VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock in Q4 2023; review adjacent reporting periods for trend context.

VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX)

CUSIP: G9495L109

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Stock
Total 13F shares: 0
Share change: -33,509
Total reported value: $0
Price per share: $0.33
Number of holders: 0
Value change: -$10,891
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP G9495L109?
CUSIP G9495L109 identifies VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q3 2023

Recent filing periods for CUSIP G9495L109:

Q4 2025 Q3 2025 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022

VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX)

Q4 2023 13F Holders as of 31 Dec 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock as of Q4 2023.